Emerging Antiviral Drugs for Hepatitis C Virus

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|4|3|179-184

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.4, Iss.3, 2009-09, pp. : 179-184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reply to direct‐acting antiviral drugs and hepatitis C virus: A therapeutic revolution?

By  

CANCER, Vol. 121, Iss. 23, 2015-12 ,pp. : 4269-4270

John Wiley & Sons Inc

Access to resources Recommend Favorite

Direct‐acting antiviral drugs and hepatitis C virus: A therapeutic revolution?

By  

CANCER, Vol. 121, Iss. 23, 2015-12 ,pp. : 4268-4269

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antiviral and Immunoregulatory Effects of Indoleamine-2,3-Dioxygenase in Hepatitis C Virus Infection

By  

Journal of Innate Immunity, Vol. 7, Iss. 5, 2015-03 ,pp. : 530-544

Karger

Access to resources Recommend Favorite

Immunological aspects of antiviral therapy of chronic hepatitis B virus and hepatitis C virus infections

By  

HEPATOLOGY, Vol. 61, Iss. 2, 2015-02 ,pp. : 712-721

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acquired hemophilia A resolution in a hepatitis C virus/human immunodeficiency virus–coinfected patient with cure of hepatitis C by direct‐acting antiviral agents

By  

HEPATOLOGY, Vol. 67, Iss. 2, 2018-02 ,pp. : 794-796

John Wiley & Sons Inc

Access to resources Recommend Favorite